Table 1.
Demographic and clinical characteristics of arbovirus patients with neurological complications.
| Demographic and clinical data | Patients with neurological complications | Patients without neurological complications | |||
|---|---|---|---|---|---|
| (N/Total) | % | (N/Total) | % | ||
| Age (years) | 174/175 | 10/10 | |||
| Median | 48.00 | 61.00 | |||
| Mean ± SD | 46.20 ± 18.45 | 63.50 ± 4.34 | |||
| Gender | |||||
| Male | 80/175 | 45.71% | 3/10 | 30.0% | |
| Female | 95/175 | 54.29% | 7/10 | 70.0% | |
| Systemic manifestation | |||||
| Fever | 132/175 | 75.42% | 8/10 | 80.0% | |
| Rash | 156/175 | 89.14% | 3/10 | 30.0% | |
| Myalgia | 113/175 | 64.57% | 8/10 | 80.0% | |
| Arthralgia | 131/175 | 74.80% | 9/10 | 90.0% | |
| Neurological signs and symptoms | |||||
| Headache | 114/175 | 65.14% | |||
| Altered consciousness | 44/175 | 25.14% | |||
| Limb weakness | 123/175 | 70.28% | |||
| Paraparesis | 130/175 | 74.28% | |||
| Quadriparesis | 121/175 | 69.14% | |||
| Neurological manifestation | |||||
| Encephalitis Spectrum Disorder | 43/175 | 24.57% | |||
| Guillain-Barré Syndrome | 46/175 | 26.29% | |||
| Myelitis | 24/175 | 13.71% | |||
| Optic Neuritis | 19/175 | 10.86% | |||
| Other Syndromes | 43/175 | 24.57% | |||
| Virological Diagnosis | |||||
| ZIKV+ | 27/174 | 15.52% | 0/10 | 0.0% | |
| DENV+ | 5/174 | 2.87% | 1/10 | 10.0% | |
| CHIKV+ | 45/174 | 25.86% | 0/10 | 0.0% | |
| CHIK+/ZIKV+ | 41/174 | 23.56% | |||
| CHIK+/DENV+ | 5/174 | 2.87% | 8/10 | 80.0% | |
| ZIKV+/DENV+ | 3/174 | 1.72% | |||
| CHIKV+/ZIKV+/DENV+ | 9/174 | 5.17% | |||
| Negative/Inconclusive | 39/174 | 22.41% | 1/10 | 10.0% | |
ZIKV+: positive test for Zika virus; DENV+: positive test for Dengue virus; CHIKV+: positive test for Chikungunya virus.